Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-α

European Journal of Pharmacology

Volumn 604, Issue 1-3, 2009, Pages 12-19

  Okamoto, Hiroshi ^a   Kimura, Mitsutoshi ^a   Watanabe, Noriyuki ^a   Ogihara, Masahiko ^a  

^a JOSAI UNIVERSITY   (Japan)

Author keywords

(Adult rat); DNA synthesis; Hepatocyte; Proliferation; Signal transduction; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2',3' DIDEOXYADENOSINE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCLONAL ANTIBODY; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NEUTRALIZING ANTIBODY; PROTEIN TYROSINE KINASE; RAPAMYCIN; SOMATOSTATIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; LIVER CELL; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATOCYTES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58949102767     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.12.004     Document Type: Article

References (50)

1. Akerman P., Cote P., Yang S.Q., McClain C., Nelson S., Bagby G.J., and Diehl A.M. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263 (1992) G579-G589
2. Alessi D., Cuenda A., Cohen P., Dudley D., and Staltiel A. PD098059 is a specific inhibitor of MAP kinase kinase-1 in vitro and in vivo. J. Biol. Chem. 270 (1995) 27489-27494
3. Andus T., Bauer J., and Gerok W. Effects of cytokines on the liver. Hepatology 13 (1991) 364-375
4. Baeulerle P.A., and Baltimore D. NF-kB: ten years after. Cell 87 (1996) 13-20
5. Brockhaus M., Schoenfeld H.J., Schlaeger E.J., Hunziker W., Lesslauer W., and Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3127-3131
6. Carswell E.A., Old L.J., Kassel S., Green N., Fiore N., and Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 3666-3670
7. Chung J., Kuo C.D., Crabtree G.R., and Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation and signaling by the 70 kD S6 protein kinases. Cell 69 (1992) 1227-1236
8. Fausto N., Cambell J.S., and Riehle K.J. Liver regeneration. Hepatology 43 (2006) S45-S53
9. Fendly B.M., and Palladino Jr. M.A. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151 (1993) 4637-4641
10. 3-induced hepatocyte proliferation in vivo. Biol. Chem. 388 (2007) 831-837
11. Fiers W. Tumor necrosis factor: characterization at the molecular, cellular, and in vivo level. FEBS Lett. 285 (1991) 199-212
12. 1 transition of rat hepatocytes following establishment in primary culture. FEBS Lett. 245 (1989) 117-121
13. Grell M., Becke F.M., Wajant H., Mannel D.N., and Scheurich P. TNF receptor type 2 mediates thymocytes proliferation independently of TNF receptor type 1. Eur. J. Immunol. 28 (1998) 257-263
14. Holgate S.T., Lewis R.A., and Austen K.F. Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 6800-6804
15. Kalb A., Bluethmann H., Moor M.W., and Lesslauer W. Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics. J. Biol. Chem. 271 (1996) 28097-28104
16. Kimura M., and Ogihara M. Density-dependent proliferation of adult rat hepatocytes in primary culture induced by epidermal growth factor is potentiated by cAMP-elevating agents. Eur. J. Pharmacol. 324 (1997) 267-276
17. Kimura M., and Ogihara M. Effects of branched-chain amino acids on DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. Eur. J. Pharmacol. 510 (2005) 167-180
18. 1) receptor agonist-induced DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: the involvement of TGF-α. Endocrinology 142 (2001) 4428-4440
19. Kimura T., Sakaida I., Terai S., Matsumura Y., Uchida K., and Okita K. Inhibition of tumor necrosis factor-α production retards liver regeneration after partial hepatectomy in rats. Biochem. Biophys. Res. Commun. 231 (1997) 557-560
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
21. Lee M.B., and Paxman S. Modification of the Lowry procedure for the analysis of proteolipid protein. Anal. Biochem. 47 (1972) 184-192
22. Lee D.C., Fenton S.E., Berkowitz E.A., and Hissong M.A. Transforming growth factor α: regulation, and biological activities. Pharmacol. Rev. 47 (1995) 51-85
23. Levitzki A., and Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 267 (1995) 1782-1788
24. Lewis M., Tartaglia L.A., Lee A., Bennet G.L., Rice G.C., Wong G.H.W., Chen E.Y., and Goeddel D.V. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2830-2834
25. Mackay F., Rothe J., Bluethmann H., Loetscher H., and Lesslauer W. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-α activation. J. Immunol. 153 (1994) 5274-5284
26. Michalopoulos G.K. Control mechanisms of liver regeneration. J. Gastroenterol. 213 (1994) 286-300
27. Michalopoulos G.K. Liver regeneration. J. Cell Physiol. 213 (2007) 286-300
28. Michalopoulos G.K., and DeFrances M.C. Liver regeneration. Science 276 (1997) 60-66
29. 3H-thymidine for measurement of DNA synthesis in rat liver-a warning. Anal. Biochem. 45 (1972) 298-305
30. Naume B., Shalaby R., Lesslauer W., and Espevik T. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. J. Immunol. 146 (1991) 3045-3048
31. Nakamura T., Tomita Y., and Ichihara A. Density-dependent growth control of adult rat hepatocytes in primary culture. J. Biochem. 94 (1983) 1029-1035
32. Price D.J., Grove J.R., Calvo V., Avruch J., and Bierer B.E. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257 (1992) 973-977
33. Rodbell M. The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 284 (1980) 17-22
34. Rothe M., Wong S.C., Henzel W.J., and Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78 (1994) 681-692
35. Seglen P.O. Preparation of isolated liver cells. Methods Cell Biol. 13 (1975) 29-83
36. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., and Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-kB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9792-9796
37. Tartaglia L.A., Goeddel D.V., Reynolds C., Figari I.S., Weber R.F., Fendly B.M., and Palladino Jr. M.A. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151 (1993) 4637-4641
38. Tartaglia L.A., Weber R.F., Figari I.S., Reynolds C., Palladino M.A., and Goeddel D.V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 9292-9296
39. Twobin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4350-4354
40. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269 (1994) 5241-5248
41. Vietor I., Schwenger P., Li W., Schlessinger J., and Vilcek J. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein kinase in human fibroblasts. J. Biol. Chem. 268 (1993) 18994-18999
42. Wallach D., Varfolomeev E., Malinin N.L., Goltsev Y.V., Kovalenko V., and Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17 (1999) 331-367
43. Watanabe Y., Osaki H., and Akaike T. TNF-α bifunctionally induces proliferation in primary hepatocytes: role of cell anchorage and spreading. J. Immunol. 159 (1997) 4840-4847
44. Weber E.M., Bruix J., Pierce R.H., and Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. J. Biol. Chem. 28 (1998) 1226-1234
45. White B., Schmidt M., Murphy C., Livingstone W., O'Toole D., Lawler M., O'Neill L., Kelleher D., Schwarz H.P., and Smith O.P. Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kB (NF-kB) and tumor necrosis factor α (TNF-α) production in the THP-1 monocytic cell line. Br. J. Haematol. 110 (2000) 130-134
46. Yamada Y., and Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am. J. Pathol., 152 (1998) 1577-1589
47. Yamada Y., Kirillova I., Peschon J.J., and Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1441-1446
48. Yamada Y., Webber E.M., Kirillova I., Peschon J.J., and Fausto N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 28 (1998) 959-970
49. Zhang Y., Lin J.-X., Yip Y.-K., and Vilcek J. Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 6802-6805
50. Zusick M.J., Puzas J.E., Rosier R.N., Gunter K.K., and Gunter T.E. Cyclic-AMP-dependent protein kinase activity is not required by parathyroid hormone to stimulate phosphoinositide signaling in chondrocytes but is required to transduce the hormone's proliferative effect. Arch. Biochem. Biophys. 315 (1994) 352-361